Are embryos people? Reproductive medicine's future depends on the answer

AhumaneightcellembryoforIVFselection.K.HardyviaWellcomeCollectionTheannouncementthatSupremeCourtJust PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year




explore

author：focus    Page View：8141
Alexis Borisy
Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In
Previous article： Readout Newsletter: GSK, Viking Therapeutics, mifepristone news
Next article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections